1 - L1_INFLIXIMAB (DOE)
Deadline:17 Jun 2026, 00:00 CEST
Tender information
TED EUVitoria-Gasteiz, Spain
- Type
- 16
- Procedure
- open
- Ref. number
- 341515-2026
- Estimated value
- 31,268,640 EUR
- CPV
- 33600000
Suministro de Infliximab (DOE), Ustekinumab (DOE) y Bevacizumab (DOE)